All Industries

Top Oncology Companies

119 Oncology companies, sorted by total funding raised.

AffimedIPO

German-domiciled and NASDAQ-traded company developing a variety of immuno-oncology therapeutics.

Heidelberg, Germany51–200Biotech, Oncology
Series E·$101.0M·Sep 2014
Stipple Bio

Biotech developing precision cancer therapies.

Cambridge, United StatesBiotech, Oncology
Series A·$100.0M·Apr 2026
VYRIAD INC

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

ROCHESTER, United States11–50Biotech, Oncology
Series B·$95.0M·Dec 2025
Cleave Biosciences

Discovering and developing novel small molecule therapies for difficult-to-treat cancers

Burlingame, United States11–50Biotech, Oncology
Series B·$89.0M·Aug 2016
Storm Therapeutics

RNA-targeting cancer drug discovery and development company.

Cambridge, United States11–50Biotech, Healthcare
Series C·$86.0M·May 2026
Recludix Pharma

Recludix is a leader in developing platform approaches to discover potent and selective inhibitor...

San Diego11–50Biotech, Oncology
Series B·$81.5M·Jan 2026
Notable LabsIPO

Personalized drug discovery for blood cancer.

Foster City, United States11–50Biotech, Drug Discovery
Venture Unknown·$77.4M·Feb 2023
PMV PharmaIPO

Precision oncology company developing first-in-class small molecule therapies that reactivate mut...

Princeton, United States11–50Biotech, Oncology
Series B·$74.0M·Dec 2014
Alpha Biopharma

专注于创新药物从临床研发到商业化运作成功;致力于开发临床急需的创新治疗药物

Shanghai, China11–50Biotech, Oncology
Series B·$73.0M·Apr 2022
Loxo OncologyClosed

Biopharma company developing targeted cancer therapies for genetically-defined patient populations

United States51–200Biotech, Oncology
Series B·$57.0M·May 2014
VeracyteIPO

Veracyte is a global cancer diagnostics company that provides genomic tests to help clinicians di...

South San Francisco, United States501–1000Biotech, Diagnostics
Series C·$56.3M·Jun 2013
Hope Medicine

Hope Medicine (HopeMed) is a clinical-stage biopharmaceutical company focused on researching, dev...

Shanghai, ChinaBiotech, Oncology
Venture Unknown·$56.0M·Feb 2024
Crown Bioscience

Global contract research organization providing preclinical and translational research services t...

San Diego, United States501–1000Preclinical Research, Oncology
Series D·$55.4M·May 2014
Paige

AI-powered computational pathology platform for cancer diagnosis and treatment, spun out of Memor...

New York, United States51–200AI, Digital Health
Series B·$45.0M·Dec 2019
PersonalisIPO

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biophar...

Menlo Park, United States201–500Genomics, Life Sciences
Series C·$33.0M·Jan 2015
Mondego Bio

Developing best-in-class PTPN2 inhibitors to advance breakthrough cancer immunotherapies with imp...

PortugalBiotech, Oncology
Series A·$22.3M·Sep 2025
Asieris PharmaceuticalsIPO

Clinical-stage biopharmaceutical company focused on developing novel therapies for oncology and u...

Shanghai, China51–200Biotech, Oncology
Series D·$14.0M
Lexent BioAcquired

Developed liquid biopsy platforms for cancer monitoring and genomic diagnostics.

San Francisco, United States11–50Biotech, Oncology
Venture Unknown·$10.2M
Preveta

Preveta is transforming cancer care by building the richest database of patient insights that wil...

Redondo Beach, United States11–50Data & Analytics, Digital Health
Venture Unknown·$8.2M·Sep 2025
Flatiron HealthAcquired

Health technology company building oncology-specific electronic health record software and curati...

New York, United States501–1000Analytics, Healthcare
Series A·$8.0M·Jan 2013
ApollomicsIPO

Clinical-stage oncology biotech developing combination therapies for difficult-to-treat cancers i...

Foster City, United States51–200Biotech, Oncology
Bridge·$7.8M·Apr 2026
Known MedicineAcquired

Combining 3D cell culture & AI to translate drugs to clinical success

Salt Lake City, United States11–50Drug Discovery, Healthcare
Seed·$7.2M·Aug 2021
TenSixty Bio

Uses AI, cell models, and high-throughput assays to identify antibody targets and develop oncolog...

Cambridge, United States1–10Life Sciences, Artificial Intelligence
Series A·$7.2M·Aug 2022
Granza Bio

Advancing Therapeutic Delivery

San Francisco, United States1–10Biotech, Healthcare
Seed·$7.1M·Jul 2024
Cellens Inc

The most accurate non-invasive bladder cancer detection method

Boston, United States1–10Biotech, Healthcare
Seed·$6.5M·Dec 2025